A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.
As a rising high school senior, assistant professor Matthew Eckelman, spent a summer at Northeastern simulating earthquakes on a shaker table to evaluate the stability of landfill liner systems. Twenty-one years later, he’s come full circle, hosting young scholars in his lab, guiding them toward STEM careers.
Failure fosters professional growth, according to three distinguished female leaders who spoke on Wednesday at the third event in Northeastern’s Women Who Inspire Speaker series.
At the first Women Who Inspire panel, six distinguished female leaders in the medical industry shared their stories and advice with more than 75 Northeastern students, faculty, and staff, as […]